Previous studies demonstrated that in CLL treated with either CD4+ or CD8+ CAR-T cells, TN, and TCM were superior to TEM and TE in anti-tumor activity, and they showed great abilities of proliferation and cytotoxicity. Here, CD8A is linked to B-cell chronic lymphocytic leukemia.